AXSM

AXSM Stock-Based Compensation

$96.42MTTM · USD

Period ending:

AXSM FY Stock-Based CompUSD
AXSM FY Stock-Based Comp2013-12-31: $55.28K2014-12-31: $376.81K2015-12-31: $803.28K2016-12-31: $2.03M2017-12-31: $2.07M2018-12-31: $1.75M2019-12-31: $6.12M2020-12-31: $14.76M2021-12-31: $20.80M2022-12-31: $37.73M2023-12-31: $62.62M2024-12-31: $85.22M2025-12-31: $93.75M$93.75M$0.00
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AXSM stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Axsome Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
93,752,000
85,218,000
62,620,000
37,726,000
20,803,000
14,756,206
6,115,160
1,754,974
2,072,210
2,031,418
803,279
376,806
55,281

Compare stock-based compensation

All AXSM financial metrics · AXSM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.